OptiNose (OPTN)
(Delayed Data from NSDQ)
$1.17 USD
-0.05 (-4.10%)
Updated May 13, 2024 04:00 PM ET
After-Market: $1.16 -0.01 (-0.85%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
OptiNose, Inc. [OPTN]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: OptiNose, Inc.
Industry: Medical - Drugs
XHANCE Label Extension Defines First FDA Approval for CRSsNP Patients; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: OptiNose, Inc.
Industry: Medical - Drugs
Near-Term XHANCE PDUFA for First Approval in Chronic Sinusitis Without Nasal Polyps; Initiating With Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: OptiNose, Inc.
Industry: Medical - Drugs
|